enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Zepbound Weight Loss Medication Approved by FDA to Treat ...

   www.aol.com/fda-approves-weight-loss-medication...

   The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.

3. Lilly's weight-loss treatment Zepbound becomes first FDA ...

   www.aol.com/news/lillys-weight-loss-drug-zep...

   (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly ...

4. FDA approves weight loss drug from Eli Lilly that helped ...

   www.aol.com/news/fda-approves-weight-loss-drug...

   The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16 months.

5. FDA Approves Zepbound, the Most Potent Weight Loss Drug Yet - AOL

   www.aol.com/lifestyle/fda-approves-zepbound-most...

   Doctors can prescribe the drug only for people who are overweight, with a BMI of 27 to 30, if they have at least one additional risk factor associated with their excess weight, such as high blood ...

6. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   Originally available only by prescription, it was approved by the FDA for over-the-counter sale in February 2007. [32] In May 2010, the U.S. Food and Drug Administration (FDA) approved a revised label for Xenical to include new safety information about rare cases of severe liver injury that have been reported with the use of this medication. [33]

7. Sibutramine - Wikipedia

   en.wikipedia.org/wiki/Sibutramine

   It was approved by the U.S. Food and Drug Administration (FDA) in November 1997 [24] for the treatment of obesity. Sibutramine is reported to be a prodrug to two active metabolites , desmethylsibutramine (M1; BTS-54354) and didesmethylsibutramine (M2; BTS-54505), with much greater potency as monoamine reuptake inhibitors.

8. FDA approves weight-loss drug to treat sleep apnea - AOL

   www.aol.com/fda-approves-weight-loss-drug...

   The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...

9. Woman opens up about losing 123 pounds with new weight loss ...

   www.aol.com/news/fda-approves-weight-loss-drug...

   People with obesity or who are overweight and hoping to lose weight with the assistance of medication have a new option. On Nov. 8, the U.S. Food and Drug Administration approved Eli Lilly’s ...